Flow Cytometry The Flow Cytometry Core provides services to HCCC members from all 6 research programs conducting both laboratory and clinical cancer research. The mission of the Flow Cytometry Facility is to serve HCCC investigators by providing state-of-the-art Flow Cytometry Services including: 1) High speed sorting 2) Multi-parameter analysis 3) High efficiency purification of cell subsets 4) Training and assisting investigators with software programs available for interpretation and analysis of data 5) Individual training of the investigators and their laboratory personnel in the use of the bench-top instruments, which are subsequently available to them on a 24/7 basis. The Flow Cytometry Facility is in a constant process of developing new technology and services as requested and/or needed by HCCC investigators. Consultation is readily available to all investigators by the Director, the Technical Director and other support personnel in the facility. In 2009, 72 HCCC members with peer-reviewed research funding used the Flow Cytometry Facility.

Public Health Relevance

The ability to analyze the expression of molecules on the surface and within individual cells, and to sort those cells based on expression of those molecules, is an essential tool for many cancer investigators. The cancer research supported by this shared resource provides state-of-the-art facilities and outstanding expertise in Flow Cytometry and cell sorting.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA086862-12
Application #
8381318
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-05-03
Budget End
2013-03-31
Support Year
12
Fiscal Year
2012
Total Cost
$120,208
Indirect Cost
$32,873
Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Kramara, J; Osia, B; Malkova, A (2018) Break-Induced Replication: The Where, The Why, and The How. Trends Genet 34:518-531
Garje, Rohan; An, Josiah J; Sanchez, Kevin et al. (2018) Current Landscape and the Potential Role of Hypoxia-Inducible Factors and Selenium in Clear Cell Renal Cell Carcinoma Treatment. Int J Mol Sci 19:
Soni, Neetu; Srindharan, Karthika; Kumar, Sunil et al. (2018) Arterial spin labeling perfusion: Prospective MR imaging in differentiating neoplastic from non-neoplastic intra-axial brain lesions. Neuroradiol J 31:544-553
White, Brian S; Lanc, Irena; O'Neal, Julie et al. (2018) A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5. Blood Cancer J 8:35
Hammond, E; Chan, K S; Ames, J C et al. (2018) Impact of advanced detector technology and iterative reconstruction on low-dose quantitative assessment of lung computed tomography density in a biological lung model. Med Phys :
Fehr, Anthony R; Jankevicius, Gytis; Ahel, Ivan et al. (2018) Viral Macrodomains: Unique Mediators of Viral Replication and Pathogenesis. Trends Microbiol 26:598-610
Powers, Kyle T; Washington, M Todd (2018) Eukaryotic translesion synthesis: Choosing the right tool for the job. DNA Repair (Amst) :
Schroeder, Mary C; Rastogi, Priya; Geyer Jr, Charles E et al. (2018) Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014. Oncologist 23:481-488
US Preventive Services Task Force; Grossman, David C; Curry, Susan J et al. (2018) Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 319:1134-1142
Katz, David A; Stewart, Kenda R; Paez, Monica et al. (2018) Development of a Discrete Choice Experiment (DCE) Questionnaire to Understand Veterans' Preferences for Tobacco Treatment in Primary Care. Patient 11:649-663

Showing the most recent 10 out of 1080 publications